This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Nanjing Sanhome Pharmaceutical Co., Ltd.. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: The Innovations of Zaijin Teng
Introduction
Zaijin Teng is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-anaerobic infection drugs. His work focuses on improving the efficacy and safety of treatments for bacterial infections.
Latest Patents
Zaijin Teng holds a patent for the use of levo-ornidazole in the preparation of anti-anaerobic bacteria infection drugs. This patent highlights the advantages of levo-ornidazole, which exhibits lower toxicity and fewer central inhibition effects compared to dextro-ornidazole or racemic ornidazole. The pharmacokinetics of L-ornidazole are superior to those of racemic ornidazole, and its anti-anaerobic activities are either slightly better or substantially the same as those of the racemic variant. This invention also details a preparation process for formulating L-ornidazole into pharmaceutical preparations suitable for clinical use.
Career Highlights
Zaijin Teng is associated with Nanjing Sanhome Pharmaceutical Co., Ltd., where he continues to innovate in the pharmaceutical industry. His work has been instrumental in advancing treatments for bacterial infections, showcasing his commitment to improving healthcare outcomes.
Collaborations
He collaborates with talented coworkers, including Cang Zhang and Li Li, who contribute to the research and development efforts at Nanjing Sanhome Pharmaceutical Co., Ltd.
Conclusion
Zaijin Teng's contributions to the field of pharmaceuticals, particularly through his patent on levo-ornidazole, demonstrate his dedication to enhancing medical treatments. His work not only addresses critical health issues but also sets a foundation for future innovations in the industry.